Explore Our Interactive Pipeline
GSK oncology is committed to the discovery and development of new oncology compounds that leverage patient-driven science to deliver improved outcomes for more patients.
12345
This interactive site provides an overview of clinical trials for assets within our GSK pipeline distributed across 4 pillars: immuno-oncology, oncology cell therapy, cancer epigenetics, and synthetic lethality.
${articleImageText}